Suppr超能文献

体内RNA干扰表明Nramp1在改变1型糖尿病易感性方面发挥作用。

In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes.

作者信息

Kissler Stephan, Stern Patrick, Takahashi Kazue, Hunter Kara, Peterson Laurence B, Wicker Linda S

机构信息

Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

出版信息

Nat Genet. 2006 Apr;38(4):479-83. doi: 10.1038/ng1766. Epub 2006 Mar 19.

Abstract

Type 1 diabetes is an autoimmune disease influenced by multiple genetic loci. Although more than 20 insulin-dependent diabetes (Idd) loci have been implicated in the nonobese diabetic (NOD) mouse model, few causal gene variants have been identified. Here we show that RNA interference (RNAi) can be used to probe candidate genes in this disease model. Slc11a1 encodes a phagosomal ion transporter, Nramp1, that affects resistance to intracellular pathogens and influences antigen presentation. This gene is the strongest candidate among the 42 genes in the Idd5.2 region; a naturally occurring mutation in the protective Idd5.2 haplotype results in loss of function of the Nramp1 protein. Using lentiviral transgenesis, we generated NOD mice in which Slc11a1 is silenced by RNAi. Silencing reduced the frequency of type 1 diabetes, mimicking the protective Idd5.2 region. Our results demonstrate a role for Slc11a1 in modifying susceptibility to type 1 diabetes and illustrate that RNAi can be used to study causal genes in a mammalian model organism.

摘要

1型糖尿病是一种受多个基因位点影响的自身免疫性疾病。尽管在非肥胖糖尿病(NOD)小鼠模型中已发现20多个胰岛素依赖型糖尿病(Idd)基因位点,但已鉴定出的致病基因变异却很少。在此,我们表明RNA干扰(RNAi)可用于在该疾病模型中探究候选基因。Slc11a1编码一种吞噬体离子转运蛋白Nramp1,它影响对细胞内病原体的抗性并影响抗原呈递。该基因是Idd5.2区域42个基因中最有力的候选基因;保护性Idd5.2单倍型中的一个自然发生的突变导致Nramp1蛋白功能丧失。利用慢病毒转基因技术,我们培育出了通过RNAi使Slc11a1沉默的NOD小鼠。沉默降低了1型糖尿病的发病率,类似于保护性Idd5.2区域的作用。我们的结果证明了Slc11a1在改变1型糖尿病易感性方面的作用,并表明RNAi可用于研究哺乳动物模式生物中的致病基因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验